ATE369849T1 - Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen - Google Patents

Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen

Info

Publication number
ATE369849T1
ATE369849T1 AT03712286T AT03712286T ATE369849T1 AT E369849 T1 ATE369849 T1 AT E369849T1 AT 03712286 T AT03712286 T AT 03712286T AT 03712286 T AT03712286 T AT 03712286T AT E369849 T1 ATE369849 T1 AT E369849T1
Authority
AT
Austria
Prior art keywords
treatment
parasitic diseases
acid derivatives
haloacetamidobenzoic
haloacetamidobenzoic acid
Prior art date
Application number
AT03712286T
Other languages
English (en)
Inventor
Patrice Lepape
Esther Fellous
Julius Bekesi
Original Assignee
Kalil Fihlo Jorge Elias
Patrice Lepape
Fellous Esther S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kalil Fihlo Jorge Elias, Patrice Lepape, Fellous Esther S A filed Critical Kalil Fihlo Jorge Elias
Application granted granted Critical
Publication of ATE369849T1 publication Critical patent/ATE369849T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03712286T 2002-01-31 2003-01-31 Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen ATE369849T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0201151A FR2835253B1 (fr) 2002-01-31 2002-01-31 Composes, en particulier de derives urees ou esters de l'acide haloacetamidobenzoique et leur utilisation pour le traitement de maladies parasitaires

Publications (1)

Publication Number Publication Date
ATE369849T1 true ATE369849T1 (de) 2007-09-15

Family

ID=27619780

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03712286T ATE369849T1 (de) 2002-01-31 2003-01-31 Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen

Country Status (10)

Country Link
US (1) US20050165068A1 (de)
EP (1) EP1469845B1 (de)
CN (1) CN100490799C (de)
AT (1) ATE369849T1 (de)
AU (1) AU2003216965A1 (de)
BR (1) BR0307039A (de)
DE (1) DE60315597T2 (de)
ES (1) ES2295567T3 (de)
FR (1) FR2835253B1 (de)
WO (1) WO2003063858A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10227320B2 (en) 2015-05-06 2019-03-12 University Of Maryland, College Park Compounds for treating parasitic infections
WO2017127627A1 (en) 2016-01-21 2017-07-27 The University Of North Carolina At Chapel Hill Compounds for treatment of trypanosomes and neurological pathogens and uses thereof
CN110996939A (zh) * 2017-08-03 2020-04-10 诺克斯生物公司 用于治疗皮肤利什曼病的方法的组合物
EP3449906A1 (de) 2017-09-04 2019-03-06 AC Biotech Topische zusammensetzungen zur verwendung in der behandlung von kutaner leishmaniose

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE106502C (de) *
JPS5848545B2 (ja) * 1974-04-18 1983-10-28 キツセイヤクヒンコウギヨウ カブシキガイシヤ シンキホウコウゾクカルボンサンアミドユウドウタイ ノ セイゾウホウホウ
US5886025A (en) * 1997-03-06 1999-03-23 Baylor University Anti-mitotic agents which inhibit tubulin polymerization
CN1181817C (zh) * 1998-03-20 2004-12-29 第一三得利制药株式会社 以苯基甲苯醌为有效成分的NF-kB抑制剂
US6294695B1 (en) * 1998-03-26 2001-09-25 Mount Sinai School Of Medicine Of The City University Of New York Aminobenzoic acid derivatives having anti-tumorigenic activity methods of making and using the same
AU7511800A (en) * 1999-08-30 2001-03-26 K.U. Leuven Research And Development Novel target for antiparasitic agents and inhibitors thereof
US7259278B2 (en) * 2000-11-29 2007-08-21 Cytoskeleton Inc. Anti-S-phase tubulin ligands

Also Published As

Publication number Publication date
WO2003063858A2 (fr) 2003-08-07
BR0307039A (pt) 2004-10-26
DE60315597T2 (de) 2008-05-08
FR2835253B1 (fr) 2008-02-01
EP1469845B1 (de) 2007-08-15
FR2835253A1 (fr) 2003-08-01
ES2295567T3 (es) 2008-04-16
US20050165068A1 (en) 2005-07-28
CN1625396A (zh) 2005-06-08
CN100490799C (zh) 2009-05-27
DE60315597D1 (de) 2007-09-27
AU2003216965A1 (en) 2003-09-02
EP1469845A2 (de) 2004-10-27
WO2003063858A3 (fr) 2004-03-25

Similar Documents

Publication Publication Date Title
ATE408601T1 (de) Fredericamycin-derivate
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
ATE365720T1 (de) Agonisten von beta-adrenorezeptoren
CY1109422T1 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
BR0312729A (pt) Novos derivados de indol-3-enxofre
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
BG108450A (en) Aromatic dicarboxylic acid derivatives
BR0012450A (pt) Benzimidazóis substituìdos
ATE548354T1 (de) Ureido-substituierte benzoesäureverbindungen und ihre verwendung für die nonsense-suppression und behandlung von erkrankungen
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
DE60303238D1 (de) Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
ATE420099T1 (de) Medikament zur wachstumsinhibierung von tumoren
SE9903894D0 (sv) Novel compounds
EA200401319A1 (ru) Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
ATE369849T1 (de) Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen
NO20063859L (no) Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter
EA200600115A1 (ru) Производные 2-аминобензойной кислоты

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties